Overdoses

  • Epidemiology of toxicology emergencies
    • Review of epidemiology of poisoning
      • Local
      • Regional
      • National
    • National Resources for Poisoning
      • National Poison Control Center
      • National Courses in Toxicology
      • Centers for Disease Control and Prevention (CDC)
    • Types of toxicological emergencies
      • Unintentional poisoning
        • Dosage errors
        • Idiosyncratic reactions
        • Childhood poisoning
        • Environmental exposure
        • Occupational exposures
      • Drug/ alcohol abuse
      • Intentional poisoning/ overdose
        • Chemical warfare
        • Assault/ homicide
        • Suicide attempts
    • Pharmacokinetics
    • Routes of absorption
      • Ingestion
      • Inhalation
      • Injection
      • Absorption
    • Poisoning by ingestion
      • Examples
      • Anatomy and physiology review
        • Absorption
        • Distribution
      • Assessment findings
      • General management considerations
    • Poisoning by inhalation
      • Examples
      • Anatomy and physiology review
        • Absorption
        • Distribution
      • Assessment findings
      • General management considerations
    • Poisoning by injection
      • Examples
        • Intravenous drug abuse
        • Venomous bites and stings
      • Anatomy and physiology review
        • Absorption
        • Distribution
      • Assessment findings
      • General management considerations
    • Poisoning by absorption
      • Examples
      • Anatomy and physiology review
        • Absorption
        • Distribution
      • Assessment findings
      • General management considerations
  • Toxic syndromes (Toxidromes) including drugs of abuse
    • Introduction--Pathophysiology, incidence, toxic agents, risk factors, methods of transmission, complications
    • Cholinergics
      • Common causative agents - pesticides (organophosphates, carbamates) and nerve agents (Sarin, Soman)
      • Assessment findings and symptoms for patients with exposure to cholinergics
        • Headache, dizziness, weakness, nausea
        • SLUDGE (salivation, lacrimation, urination, defecation, GI Upset, Emesis)
        • Bradycardia, wheezing, bronchoconstriction, myosis, coma, convulsions
        • Diaphoresis, seizures
      • Management for a patient with exposure to cholinergics
        • Decontamination
        • Airway and ventilation and circulation
        • Pharmacological
          • atropine
          • pralidoxime chloride (2-PAM)
          • diazepam
          • activated charcoal
        • Non-pharmacological
    • Anticholinergic
      • Common causative agents
      • Assessment findings and symptoms for patients with exposure to anticholinergics
        • Delirium, Flushed Skin, Dilated Pupils, Urinary Retention
        • Memory Loss, Seizures
      • Management for a patient with exposure to anticholinergics
        • Airway and ventilation
        • Pharmacological
        • Non-pharmacological
    • Marijuana and cannabis compounds
      • Common causative agents
      • Assessment findings and symptoms for patients with exposure/use of cannabis
      • Management for a patient with exposure to cannabis
        • Airway and ventilation and circulation
        • Pharmacological
        • Non-pharmacological
    • Sympathomimetics/Stimulates
      • Common causative agents
        • Cocaine
        • Methamphetamine
        • Ecstasy
        • ICE
        • Other
      • Assessment findings and symptoms for patients with exposure to/use of Sympathomimetics/Stimulates
        • Agitated delirium
        • Hypertensive emergencies
        • Psychosis/ seizures
        • Malignant Hyperthermia
        • Cardiac damage
      • Management for a patient with exposure to/use of Sympathomimetics/Stimulates
        • Airway and ventilation and circulation
        • Pharmacological/Sedation/restraint
        • Non-pharmacological
    • Barbiturates/sedatives/ hypnotics
      • Common causative agents
      • Assessment findings and symptoms for patients with exposure to/use of Barbiturates/sedatives/ hypnotics
        • Respiratory depression/ respiratory arrest
        • Hypotension
        • CNS
      • Management for a patient with exposure to/use of Barbiturates/sedatives/ hypnotics
        • Airway and ventilation and circulation
        • Pharmacological
        • Non-pharmacological
    • Hallucinogens
      • Common causative agents
        • lysergic acid diethylamide (LSD)
        • phencyclidine (PCP)
        • peyote, mushrooms, jimson weed, mescaline
        • Other
      • Assessment findings and symptoms for patients with exposure to/use of Hallucinogens
        • CNS and behavioral
        • Chest pain
      • Management for a patient with exposure to/use of Hallucinogens
        • Airway and ventilation and circulation
        • Pharmacological/sedation/restraint
        • Non-pharmacological
    • Opiates
      • Common causative agents
        • heroin, morphine, methadone
        • codeine, meperidine, propoxyphene
        • fentanyl, lortab, oxycontin
        • other
      • Assessment findings and symptoms for patients with exposure to/use opiates
        • CNS—Euphoria, decreased level of consciousness, sedation
        • Hypotension
        • Respiratory depression/ arrest
        • Nausea, Pinpoint pupils
        • Seizures and Coma
      • Management for a patient with exposure to/use of opiates
        • Airway and ventilation and circulation
        • Pharmacological/sedation/restraint
        • Non-pharmacological
    • Huffing Agent (Halogenated Hydrocarbons)
      • Common causative agents
      • Assessment findings and symptoms for patients with exposure to/use of Huffing agents
        • Cardiovascular collapse and Ventricular arrhythmias
        • Seizure
        • Psychosis
      • Management for a patient with exposure to/use of huffing agents
        • Airway and ventilation and circulation
        • Pharmacological/sedation/restraint
        • Non-pharmacological
  • Alcoholism
    • Introduction—Epidemiology, risk factors, morbidity/ mortality complications
    • Pathophysiology of long term and acute alcohol abuse and withdrawal
      • End organ damage
        • Brain
        • Liver
        • Heart
        • Bone
        • Pancreas
      • Assessment findings and symptoms for patients with acute and chronic alcohol abuse and withdrawal
      • Management for a patient with exposure to/use of with acute and chronic alcohol abuse and withdrawal
        • Airway and ventilation and circulation
        • Pharmacological/restraint
        • Non-pharmacological
  • Poisonings and exposures
    • Chemicals
      • Agents
        • Cyanide
        • Solvents
        • Carbon monoxide
        • Alcohols
        • Hydrocarbons
        • Caustics
        • Metals
        • Hydrogen Fluoride
        • Hydrogen Sulfide
        • Oxides of Nitrogen
        • Ammonia
        • Chlorine
      • Assessment findings and symptoms for patients with chemical poisoning/exposure
      • Management for a patient with chemical poisoning/exposure
        • Airway and ventilation and circulation
        • Pharmacological
        • Non-pharmacological
  • Household Poisons
    • Pesticides
      • Organophosphates
      • Carbamates
      • Warfarins
      • Pyrethrums (Raid)
    • Household Cleaning poisonings
      • Bleach
      • Cleaning agents
      • Pine oil products
    • Poisonous Plants
      • China Berry
      • Foxglove
      • Mistletoe
      • Dieffenbachia
      • Others
    • Assessment findings and symptoms for patients with poisoning/exposure to household poisons
    • Management for a patient with chemical poisoning/exposure to household poisons
      • Airway and ventilation and circulation
      • Pharmacological
      • Non-pharmacological
  • Medication overdose-- Introduction--Pathophysiology, incidence, toxic agents, risk factors, complications
    • Cardiac medications
    • Psychiatric medications
    • Non-prescription pain medications including Salicylates and Acetaminophen
    • Other
    • Assessment findings and symptoms for patients with medication overdose
    • Management for a patient with medication overdose
      • Airway and ventilation and circulation
      • Pharmacologic
      • Non-pharmacologic
  • General Treatment modalities for Poisonings
    • Facilitated Airway Control
    • Respiratory Support
    • Circulation Support
    • Antidote Therapy
      • Methylene Blue
      • Cyanide Antidotes
      • Physostigmine
      • Alkalization and Sodium Bicarbonate
      • Atropine and Pralidoxime (2-PAM)
      • Narcan
      • Sedatives
      • Solu-medrol, decadron
      • Beta Agonist
      • Ipecac
      • Haldol
      • Glucagon
      • Flumazenil
      • Dimercapel
      • Digibind
      • Calcium Gluconate
      • Activated Charcoal
    • Decontamination
  • Communication and documentation for patients with toxicological emergencies
  • Transport decisions with toxicological emergencies
  • Age-related variations for pediatric and geriatric patients
  • Patient education and prevention of toxicological emergencies and drug and alcohol abuse

Content Creator: Nathan Werner
CAPCE Course Number: 21-EMTP-F3-1321
Total CE Hours: 1
Level: Advanced
EMT-CE uses the NEMSES guidelines as the foundation for every course outline.